Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT-SIH: Pre-emptive NPH Insulin for Preventing Hyperglycaemia After Knee Steroid Injection
NCT07757464Phase 2Active, not recruiting
- Sponsor
- Shifa International Hospital
- Start
- Aug 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 2 trial of insulin isophane in hyperglycemia, sponsored by Shifa International Hospital. Started Aug 2026; status: active, not recruiting.
02
Drugs
insulin isophane
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT07757464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07757464.